Table 4. Open in new tab Prevalence...

Characteristic	Woman-Types	PR (95% CI)
Age5	15675	48	1.01^a (.66–1.52)
Marital status
Unmarried or separated	5786	26	1.00 (reference)
Married or living with a partner	9736	22	0.50 (.22–1.13)
Race
White	12745	41	1.00 (reference)
Nonwhite	2930	7	0.74 (.30–1.86)
Ever had genital warts
No	13380	41	1.00 (reference)
Yes	2142	7	1.07 (.37–3.09)
Smoking status^b
Never	11521	31	1.00 (reference)
Former	3287	14	1.58 (.62–4.03)
Current	663	3	1.68 (.24–11.77)
Has immunosuppressive condition^c
No	15318	47	1.00 (reference)
Yes	204	1	1.60 (.28–9.19)
Consumes alcoholic beverages
No	2346	8	1.00 (reference)
Yes	13176	40	0.89 (.33–2.38)
Male sex partners, lifetime no. (tertiles)
0–4	4868	11	1.00 (reference)
5–11	4845	17	1.55 (.47–5.13)
≥12	5531	20	1.60 (.52–4.91)
New male sex partner in past 12 mo
No	11391	32	1.00 (reference)
Yes	3672	12	1.16 (.40–3.42)
Male or female open-mouth kissing partners, lifetime no. (median split)^d
0–15	5888	15	1.00 (reference)
≥16	6064	22	1.42 (.54–3.77)
Male or female oral sex partners, lifetime no. (median split)^d
0–5	6217	18	1.00 (reference)
≥6	5990	19	1.10 (.42–2.86)

Characteristic

Woman-Types

PR (95% CI)

Analyzed

Determined to Be Oral γ-HPV Positive

Age5

15675

1.01^a (.66–1.52)

Marital status

Unmarried or separated

5786

1.00 (reference)

Married or living with a partner

9736

0.50 (.22–1.13)

Race

White

12745

1.00 (reference)

Nonwhite

2930

0.74 (.30–1.86)

Ever had genital warts

13380

1.00 (reference)

Yes

2142

1.07 (.37–3.09)

Smoking status^b

Never

11521

1.00 (reference)

Former

3287

1.58 (.62–4.03)

Current

663

1.68 (.24–11.77)

Has immunosuppressive condition^c

15318

1.00 (reference)

Yes

204

1.60 (.28–9.19)

Consumes alcoholic beverages

2346

1.00 (reference)

Yes

13176

0.89 (.33–2.38)

Male sex partners, lifetime no. (tertiles)

0–4

4868

1.00 (reference)

5–11

4845

1.55 (.47–5.13)

≥12

5531

1.60 (.52–4.91)

New male sex partner in past 12 mo

11391

1.00 (reference)

Yes

3672

1.16 (.40–3.42)

Male or female open-mouth kissing partners, lifetime no. (median split)^d

0–15

5888

1.00 (reference)

≥16

6064

1.42 (.54–3.77)

Male or female oral sex partners, lifetime no. (median split)^d

0–5

6217

1.00 (reference)

≥6

5990

1.10 (.42–2.86)

Characteristic	Woman-Types	PR (95% CI)
Age5	15675	48	1.01^a (.66–1.52)
Marital status
Unmarried or separated	5786	26	1.00 (reference)
Married or living with a partner	9736	22	0.50 (.22–1.13)
Race
White	12745	41	1.00 (reference)
Nonwhite	2930	7	0.74 (.30–1.86)
Ever had genital warts
No	13380	41	1.00 (reference)
Yes	2142	7	1.07 (.37–3.09)
Smoking status^b
Never	11521	31	1.00 (reference)
Former	3287	14	1.58 (.62–4.03)
Current	663	3	1.68 (.24–11.77)
Has immunosuppressive condition^c
No	15318	47	1.00 (reference)
Yes	204	1	1.60 (.28–9.19)
Consumes alcoholic beverages
No	2346	8	1.00 (reference)
Yes	13176	40	0.89 (.33–2.38)
Male sex partners, lifetime no. (tertiles)
0–4	4868	11	1.00 (reference)
5–11	4845	17	1.55 (.47–5.13)
≥12	5531	20	1.60 (.52–4.91)
New male sex partner in past 12 mo
No	11391	32	1.00 (reference)
Yes	3672	12	1.16 (.40–3.42)
Male or female open-mouth kissing partners, lifetime no. (median split)^d
0–15	5888	15	1.00 (reference)
≥16	6064	22	1.42 (.54–3.77)
Male or female oral sex partners, lifetime no. (median split)^d
0–5	6217	18	1.00 (reference)
≥6	5990	19	1.10 (.42–2.86)

Table 4.

Open in new tab

Prevalence Ratios (PRs) for the Associations Between Selected Risk Factors and Type-Specific Oral γ–Human Papillomavirus (HPV) Detection Among 309 Mid-Adult Women in Seattle, Washington, 2011–2012

Characteristic	Woman-Types		PR (95% CI)
Characteristic	Analyzed	Determined to Be Oral γ-HPV Positive	PR (95% CI)
Age5	15675	48	1.01^a (.66–1.52)
Marital status
Unmarried or separated	5786	26	1.00 (reference)
Married or living with a partner	9736	22	0.50 (.22–1.13)
Race
White	12745	41	1.00 (reference)
Nonwhite	2930	7	0.74 (.30–1.86)
Ever had genital warts
No	13380	41	1.00 (reference)
Yes	2142	7	1.07 (.37–3.09)
Smoking status^b
Never	11521	31	1.00 (reference)
Former	3287	14	1.58 (.62–4.03)
Current	663	3	1.68 (.24–11.77)
Has immunosuppressive condition^c
No	15318	47	1.00 (reference)
Yes	204	1	1.60 (.28–9.19)
Consumes alcoholic beverages
No	2346	8	1.00 (reference)
Yes	13176	40	0.89 (.33–2.38)
Male sex partners, lifetime no. (tertiles)
0–4	4868	11	1.00 (reference)
5–11	4845	17	1.55 (.47–5.13)
≥12	5531	20	1.60 (.52–4.91)
New male sex partner in past 12 mo
No	11391	32	1.00 (reference)
Yes	3672	12	1.16 (.40–3.42)
Male or female open-mouth kissing partners, lifetime no. (median split)^d
0–15	5888	15	1.00 (reference)
≥16	6064	22	1.42 (.54–3.77)
Male or female oral sex partners, lifetime no. (median split)^d
0–5	6217	18	1.00 (reference)
≥6	5990	19	1.10 (.42–2.86)

Characteristic	Woman-Types		PR (95% CI)
Characteristic	Analyzed	Determined to Be Oral γ-HPV Positive	PR (95% CI)
Age5	15675	48	1.01^a (.66–1.52)
Marital status
Unmarried or separated	5786	26	1.00 (reference)
Married or living with a partner	9736	22	0.50 (.22–1.13)
Race
White	12745	41	1.00 (reference)
Nonwhite	2930	7	0.74 (.30–1.86)
Ever had genital warts
No	13380	41	1.00 (reference)
Yes	2142	7	1.07 (.37–3.09)
Smoking status^b
Never	11521	31	1.00 (reference)
Former	3287	14	1.58 (.62–4.03)
Current	663	3	1.68 (.24–11.77)
Has immunosuppressive condition^c
No	15318	47	1.00 (reference)
Yes	204	1	1.60 (.28–9.19)
Consumes alcoholic beverages
No	2346	8	1.00 (reference)
Yes	13176	40	0.89 (.33–2.38)
Male sex partners, lifetime no. (tertiles)
0–4	4868	11	1.00 (reference)
5–11	4845	17	1.55 (.47–5.13)
≥12	5531	20	1.60 (.52–4.91)
New male sex partner in past 12 mo
No	11391	32	1.00 (reference)
Yes	3672	12	1.16 (.40–3.42)
Male or female open-mouth kissing partners, lifetime no. (median split)^d
0–15	5888	15	1.00 (reference)
≥16	6064	22	1.42 (.54–3.77)
Male or female oral sex partners, lifetime no. (median split)^d
0–5	6217	18	1.00 (reference)
≥6	5990	19	1.10 (.42–2.86)

A total of 309 women contributed 15675 women-types to the oral γ-HPV analysis.

Abbreviations: Age5, age in years divided by 5; CI, confidence interval.

^aReflects the relative change in the likelihood of γ-HPV detection associated with a 5-year difference in age.

^bSmoking was defined as smoking at least 1 cigarette/day for ≥1 month; former smokers reported ever smoking but not currently smoking, and current smokers reported currently smoking.

^cIncludes human immunodeficiency virus positivity or current receipt of immunosuppressive medications.

^dRestricted to 245 women who provided information on these additional potential risk factors for oral HPV. These questions were added after the start of the study and therefore not presented to all participants.

This Feature Is Available To Subscribers Only